Syndax Pharmaceuticals Raises $6 Million in Securities Offering

Syndax Pharmaceuticals Raises $6 Million in Securities Offering
WALTHAM, Mass., Aug. 11 /PRNewswire/ — Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that it has issued $6M in convertible notes and warrants to its Series A investors bringing the total investment to date to $55M. All current investors, including Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures, Pappas Ventures and MC Life …

Read more on redOrbit